Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

The European Innovation Council supports innovative portfolios in health biotech

Nature Biotechnology volume 42, pages 1488–1492 (2024)Cite this article

The European Innovation Council aims to catalyze the formation and growth of science-based businesses in Europe through highly targeted initiatives, actively managed innovative portfolios and a stepped funding pathway of grants and equity investment.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: EIC cell therapy manufacturing portfolio projects and activities of common interest.
Fig. 2: Project origins in a future extended EIC Portfolio.

References

  1. Arzimanoglou, I. Mol. Ther. 30, 2111–2112 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hodgson, J. & Schreiber-Gregory, D. Nat. Biotechnol. 40, 821–828 (2022).

    Article  CAS  PubMed  Google Scholar 

  3. Ebikeme, C. Nature https://doi.org/10.1038/d41586-023-01268-7 (2023).

    Article  PubMed  Google Scholar 

  4. Yip, A. & Webster, R. M. Nat. Rev. Drug Discov. 17, 161–162 (2018).

    Article  CAS  PubMed  Google Scholar 

  5. Anonymous. Nat. Biotechnol. 40, 621 (2022).

  6. Midgley, P. Impact https://doi.org/10.21820/23987073.2024.1.4 (2024).

    Article  Google Scholar 

  7. Piccart, M. et al. Lancet Oncol. 22, 476–488 (2021).

    Article  CAS  PubMed  Google Scholar 

  8. Paulson, T. G. et al. Nat. Commun. 13, 2300 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bukhari, S. et al. Cell Rep. Med. 4, 100868 (2023).

    Article  CAS  PubMed  Google Scholar 

  10. Fu, Y. et al. Nat. Cancer 1, 800–810 (2020).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

I would like to acknowledge several former colleagues who helped in the preparation and internal review of this article, notably Keith Sequeira (review) at DGRTD, Ioannis Amarantos (CGT Challenge), Barbara Gerratana (ELMs Challenge), Goncalo Neto (RNA-based therapies), Penelope Stathoyannis, Vilma Radvilaite and Justyna Tisserand (Precision Oncology Challenge) and Anne-Marie Sassen and Stephane Ouaki at EIC/EISMEA (review).

Author information

Author notes

  1. Iordanis Arzimanoglou

    Present address: Senior Advisor, Health Biotech, Brussels, Belgium

Authors and Affiliations

  1. Former Program Manager for Health and Biotechnology, EIC, Brussels, Belgium

    Iordanis Arzimanoglou

Authors
  1. Iordanis Arzimanoglou
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Iordanis Arzimanoglou.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arzimanoglou, I. The European Innovation Council supports innovative portfolios in health biotech. Nat Biotechnol 42, 1488–1492 (2024). https://doi.org/10.1038/s41587-024-02416-8

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41587-024-02416-8

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing